These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 18650021)

  • 21. Metformin-associated prevention of weight gain in insulin-treated type 2 diabetic patients cannot be explained by decreased energy intake: A post hoc analysis of a randomized placebo-controlled 4.3-year trial.
    Out M; Miedema I; Jager-Wittenaar H; van der Schans C; Krijnen W; Lehert P; Stehouwer C; Kooy A
    Diabetes Obes Metab; 2018 Jan; 20(1):219-223. PubMed ID: 28681986
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metformin for prevention of weight gain and insulin resistance with olanzapine: a double-blind placebo-controlled trial.
    Baptista T; Martínez J; Lacruz A; Rangel N; Beaulieu S; Serrano A; Arapé Y; Martinez M; de Mendoza S; Teneud L; Hernández L
    Can J Psychiatry; 2006 Mar; 51(3):192-6. PubMed ID: 16618011
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metformin for treatment of antipsychotic-induced weight gain: a randomized, placebo-controlled study.
    Wang M; Tong JH; Zhu G; Liang GM; Yan HF; Wang XZ
    Schizophr Res; 2012 Jun; 138(1):54-7. PubMed ID: 22398127
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metformin as a treatment for antipsychotic drug side effects: special focus on women with schizophrenia.
    Smith RC
    Am J Psychiatry; 2012 Aug; 169(8):774-6. PubMed ID: 22854925
    [No Abstract]   [Full Text] [Related]  

  • 25. Antipsychotic-induced weight gain in patients with schizophrenia.
    Venkatasubramanian G
    JAMA; 2008 Apr; 299(16):1899; author reply 1899-900. PubMed ID: 18430906
    [No Abstract]   [Full Text] [Related]  

  • 26. Psychiatric medication-induced obesity: treatment options.
    Schwartz TL; Nihalani N; Virk S; Jindal S; Chilton M
    Obes Rev; 2004 Nov; 5(4):233-8. PubMed ID: 15458397
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metformin in an Adolescent with Significant Weight Gain.
    Salau M; Adam B; Coffey BJ
    J Child Adolesc Psychopharmacol; 2015 Sep; 25(7):589-92. PubMed ID: 26375769
    [No Abstract]   [Full Text] [Related]  

  • 28. Topiramate leukopenia on clozapine.
    Behar D; Schaller JL
    Eur Child Adolesc Psychiatry; 2004 Feb; 13(1):51-2. PubMed ID: 14991432
    [No Abstract]   [Full Text] [Related]  

  • 29. Use of metformin to control clozapine-associated weight gain in an adolescent with schizoaffective disorder.
    Weaver LA; De León DD; Borgmann-Winter K; Coffey BJ
    J Child Adolesc Psychopharmacol; 2010 Apr; 20(2):153-7. PubMed ID: 20415612
    [No Abstract]   [Full Text] [Related]  

  • 30. Metformin for obesity and glucose dysregulation in patients with schizophrenia receiving antipsychotic drugs.
    Hasnain M; Fredrickson SK; Vieweg WV
    J Psychopharmacol; 2011 Jun; 25(6):715-21. PubMed ID: 21169390
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Considering metformin in cardiometabolic protection in psychosis.
    Curtis J; Newall H; Myles N; Shiers D; Samaras K
    Acta Psychiatr Scand; 2012 Oct; 126(4):302-3. PubMed ID: 22804349
    [No Abstract]   [Full Text] [Related]  

  • 32. Metformin plus sibutramine for olanzapine-associated weight gain and metabolic dysfunction in schizophrenia: a 12-week double-blind, placebo-controlled pilot study.
    Baptista T; Uzcátegui E; Rangel N; El Fakih Y; Galeazzi T; Beaulieu S; de Baptista EA
    Psychiatry Res; 2008 May; 159(1-2):250-3. PubMed ID: 18374423
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lifestyle intervention and metformin for treatment of antipsychotic-induced weight gain: a randomized controlled trial.
    Wu RR; Zhao JP; Jin H; Shao P; Fang MS; Guo XF; He YQ; Liu YJ; Chen JD; Li LH
    JAMA; 2008 Jan; 299(2):185-93. PubMed ID: 18182600
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metformin for weight reduction in non-diabetic patients on antipsychotic drugs: a systematic review and meta-analysis.
    Björkhem-Bergman L; Asplund AB; Lindh JD
    J Psychopharmacol; 2011 Mar; 25(3):299-305. PubMed ID: 20080925
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Body weight gain induced by antipsychotic drugs: mechanisms and management.
    Baptista T
    Acta Psychiatr Scand; 1999 Jul; 100(1):3-16. PubMed ID: 10442434
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical experience with Topiramate to counteract neuroleptic induced weight gain in 10 individuals with autistic spectrum disorders.
    Canitano R
    Brain Dev; 2005 Apr; 27(3):228-32. PubMed ID: 15737706
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of atypical antipsychotic drug-induced weight gain: focus on metformin.
    Miller LJ
    Pharmacotherapy; 2009 Jun; 29(6):725-35. PubMed ID: 19476423
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Re: Weight change with antipsychotic use.
    Dewan VK
    Can J Psychiatry; 2001 Sep; 46(7):660. PubMed ID: 11582832
    [No Abstract]   [Full Text] [Related]  

  • 39. Management of weight gain associated with antipsychotics.
    Birt J
    Ann Clin Psychiatry; 2003 Mar; 15(1):49-58. PubMed ID: 12839432
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Second-generation antipsychotic use in schizophrenia and associated weight gain: a critical review and meta-analysis of behavioral and pharmacologic treatments.
    Das C; Mendez G; Jagasia S; Labbate LA
    Ann Clin Psychiatry; 2012 Aug; 24(3):225-39. PubMed ID: 22860242
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.